First-in-Human Imaging with (89)Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake

Por Pandit-Taskar, Neeta, O’Donoghue, Joseph A., Ruan, Shutian, Lyashchenko, Serge K., Carrasquillo, Jorge A., Heller, Glenn, Martinez, Danny F., Cheal, Sarah M., Lewis, Jason S., Fleisher, Martin, Keppler, Jennifer S., Reiter, Robert E., Wu, Anna M., Weber, Wolfgang A., Scher, Howard I., Larson, Steven M., Morris, Michael J.
Publicado no J Nucl Med (2016)

A Phase I/II Study for Analytic Validation of (89)Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer

Por Pandit-Taskar, Neeta, O'Donoghue, Joseph A., Durack, Jeremy C., Lyashchenko, Serge K., Cheal, Sarah M., Beylergil, Volkan, Lefkowitz, Robert A., Carrasquillo, Jorge A., Martinez, Danny F., Fung, Alex Mak, Solomon, Stephen B., Gonen, Mithat, Heller, Glenn, Loda, Massimo, Nanus, David M., Tagawa, Scott T., Feldman, Jarett L., Osborne, Joseph R., Lewis, Jason S., Reuter, Victor E., Weber, Wolfgang A., Bander, Neil H., Scher, Howard I., Larson, Steven M., Morris, Michael J.
Publicado no Clin Cancer Res (2015)